Log in to save to my catalogue

The PRoject of ex-vivo vein graft ENgineering via transfection IV (PREVENT IV) trial : Study rationa...

The PRoject of ex-vivo vein graft ENgineering via transfection IV (PREVENT IV) trial : Study rationa...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68667988

The PRoject of ex-vivo vein graft ENgineering via transfection IV (PREVENT IV) trial : Study rationale, design, and baseline patient characteristics

About this item

Full title

The PRoject of ex-vivo vein graft ENgineering via transfection IV (PREVENT IV) trial : Study rationale, design, and baseline patient characteristics

Publisher

New York, NY: Elsevier

Journal title

The American heart journal, 2005-10, Vol.150 (4), p.643-649

Language

English

Formats

Publication information

Publisher

New York, NY: Elsevier

More information

Scope and Contents

Contents

Coronary artery bypass graft (CABG) surgery with autologous vein graft (VG) conduit is one of the most frequently performed operations in the United States. Unfortunately, many VGs become occluded during long-term follow-up largely because of neointimal hyperplasia. A novel approach to preventing neointimal hyperplasia is with the double-stranded o...

Alternative Titles

Full title

The PRoject of ex-vivo vein graft ENgineering via transfection IV (PREVENT IV) trial : Study rationale, design, and baseline patient characteristics

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_68667988

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68667988

Other Identifiers

ISSN

0002-8703

E-ISSN

1097-6744

DOI

10.1016/j.ahj.2005.05.021

How to access this item